SCHEMBL6153460

SCHEMBL6153460

Oc1ccc(Oc2cccc(/C=N/NC(=S)Nc3ccc(Cl)c(Cl)c3)c2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RRM1 P23921 6/20 0.56
RRM2 P31350 6/20 0.56
RRM2B Q7LG56 6/20 0.56
KMT2A Q03164 6/20 0.52
MEN1 O00255 4/20 0.52
MAPT P10636 4/20 0.50
GAA P10253 2/20 0.50
POLB P06746 3/20 0.49
NPC1 O15118 1/20 0.49
ALDH1A1 P00352 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
LMNA P02545 1/20 0.49
XDH P47989 1/20 0.48
ASF1A Q9Y294 1/20 0.47
NPSR1 Q6W5P4 1/20 0.46
CASP3 P42574 1/20 0.46
SENP8 Q96LD8 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153416 0.81 KMT2A (0.52) KMT2AMEN1MAPTGAAPOLB
SCHEMBL6154622 0.80 SMN1; SMN2 (0.55) RRM1RRM2RRM2BKMT2AMEN1
SCHEMBL6156530 0.80 KMT2A (0.51) KMT2AMEN1MAPTGAAPOLB
SCHEMBL6665515 0.73 MAPT (0.52) RRM1RRM2RRM2BKMT2AMEN1
SCHEMBL6153669 0.73 KMT2A (0.49) RRM1RRM2RRM2BKMT2AMEN1
SCHEMBL6154732 0.70 ALDH1A1 (0.68) KMT2AMEN1MAPTGAAPOLB
SCHEMBL9219537 0.69 KMO (0.51) KMT2AMEN1MAPTNPC1ALDH1A1
SCHEMBL9219542 0.69 KMO (0.51) KMT2AMEN1MAPTNPC1ALDH1A1
SCHEMBL10354980 0.66 HSP90AA1 (0.74) KMT2AMEN1
SCHEMBL31287790 0.66 HSP90AA1 (0.74) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP RRM1 2553/4885RRM2 1166/4885RRM2B 907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.